Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 4/2011

01.04.2011 | Original Article

Prognostic Factors for Post-recurrence Survival in Esophageal Squamous Cell Carcinoma Patients with Recurrence after Resection

verfasst von: Po-Kuei Hsu, Bing-Yen Wang, Chien-Sheng Huang, Yu-Chung Wu, Wen-Hu Hsu

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

The survival of recurrent esophageal cancer is poor. But reports regarding prognostic factors for post-recurrence survival are limited. We analyzed the recurrence pattern and the prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma with recurrence after resection.

Methods

Two hundred sixty-eight patients were included. Tumor recurrence occurred in 115 (42.9%) patients. Recurrence pattern was classified as locoregional, distant, and combined recurrence. The post-recurrence survival was defined as the interval between initial recurrence and either death or the last follow-up.

Results

Mediastinum lymphadenopathy was the most common site for locoregional recurrence, whereas lung, liver, and bone were the most common sites for distant recurrence. The overall 1- and 2-year post-recurrence survival rates were 32.6% and 12.6% with a median survival after recurrence of 6.0 months. The independent prognostic factors included liver recurrence (HR = 2.255, 95%CI = 1.073–4.741, p = 0.032), time to recurrence ≤10 months (HR = 2.657, 95%CI = 1.438–4.911, p = 0.002), and no treatment for recurrences (HR = 2.745, 95%CI = 1.635–4.608, p < 0.001).

Conclusions

We identify liver recurrence, early recurrence, and no treatment for recurrence as risk factors for dismal post-recurrence survival.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA: a cancer journal for clinicians 2009;59(4):225–49.CrossRef Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA: a cancer journal for clinicians 2009;59(4):225–49.CrossRef
3.
Zurück zum Zitat Law SYK, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implication. Br J Surg 1996;83:107–11.PubMedCrossRef Law SYK, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implication. Br J Surg 1996;83:107–11.PubMedCrossRef
4.
Zurück zum Zitat Nakagawa S, Kanda T, Kosugi S, et al. Recurrence patterns of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004;198:205–11.PubMedCrossRef Nakagawa S, Kanda T, Kosugi S, et al. Recurrence patterns of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004;198:205–11.PubMedCrossRef
5.
Zurück zum Zitat Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 2000;87:1426–33.PubMedCrossRef Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 2000;87:1426–33.PubMedCrossRef
6.
Zurück zum Zitat Abate E, DeMeester SR, Zehetner J, et al. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg 2010;210:428–35.PubMedCrossRef Abate E, DeMeester SR, Zehetner J, et al. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg 2010;210:428–35.PubMedCrossRef
7.
Zurück zum Zitat Shimada H, Kitabayashi H, Nabeya Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24–31.PubMedCrossRef Shimada H, Kitabayashi H, Nabeya Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24–31.PubMedCrossRef
8.
Zurück zum Zitat Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616–23.PubMedCrossRef Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616–23.PubMedCrossRef
9.
Zurück zum Zitat Bhansali M, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997;21:275–81.PubMedCrossRef Bhansali M, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997;21:275–81.PubMedCrossRef
10.
Zurück zum Zitat Kunisaki C, Makino H, Takagawa R, et al. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg 2008;12:802–20.PubMedCrossRef Kunisaki C, Makino H, Takagawa R, et al. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg 2008;12:802–20.PubMedCrossRef
11.
Zurück zum Zitat Osugi H, Takemura M, Takada N, et al. Prognostic factors after oesophagectomy and extended lymphadebectomy for squamous oesophageal cancer. Br J Surg 2002;89:909–13.PubMedCrossRef Osugi H, Takemura M, Takada N, et al. Prognostic factors after oesophagectomy and extended lymphadebectomy for squamous oesophageal cancer. Br J Surg 2002;89:909–13.PubMedCrossRef
12.
Zurück zum Zitat Edge SB, Byrd DR, et al. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. Chicago: Springer, Inc., 2010. Edge SB, Byrd DR, et al. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. Chicago: Springer, Inc., 2010.
13.
Zurück zum Zitat National Comprehensive Cancer Network. Esophageal Cancer Clinical Practice Guidelines in Oncology (V.1.2010). Available at: www.nccn.org. National Comprehensive Cancer Network. Esophageal Cancer Clinical Practice Guidelines in Oncology (V.1.2010). Available at: www.​nccn.​org.
14.
Zurück zum Zitat Harrell FE Jr. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer, 2001. Harrell FE Jr. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer, 2001.
15.
Zurück zum Zitat Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization Nat Rev Cancer 2009;9:274–84.PubMedCrossRef Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization Nat Rev Cancer 2009;9:274–84.PubMedCrossRef
16.
Zurück zum Zitat Kim MY, Oskersson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell 2009;139:1315–26.PubMedCrossRef Kim MY, Oskersson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell 2009;139:1315–26.PubMedCrossRef
17.
Zurück zum Zitat Smit JK, Pultrum BB, van Dullemen HM, et al. Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy. Am J Surg 2010; 200:446–53.PubMedCrossRef Smit JK, Pultrum BB, van Dullemen HM, et al. Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy. Am J Surg 2010; 200:446–53.PubMedCrossRef
18.
Zurück zum Zitat Doki Y, Ishikawa O, Takachi K, et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg 2005;29:700–7.PubMedCrossRef Doki Y, Ishikawa O, Takachi K, et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg 2005;29:700–7.PubMedCrossRef
19.
Zurück zum Zitat Hulscher JB, van Sandick JW, Tijssen JG, et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 2000;191:143–8.PubMedCrossRef Hulscher JB, van Sandick JW, Tijssen JG, et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 2000;191:143–8.PubMedCrossRef
20.
Zurück zum Zitat Kato H, Tachimori Y, Watanabe H, et al. Anastomotic recurrence of oesophageal squamous cell carcinoma after transthoracic oesophagectomy. Eur J Surg 1998;164:759–64.PubMedCrossRef Kato H, Tachimori Y, Watanabe H, et al. Anastomotic recurrence of oesophageal squamous cell carcinoma after transthoracic oesophagectomy. Eur J Surg 1998;164:759–64.PubMedCrossRef
21.
Zurück zum Zitat Osugi H, Takemura M, Higashino M, et al. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 2003;10:81–7.PubMed Osugi H, Takemura M, Higashino M, et al. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus. Oncol Rep 2003;10:81–7.PubMed
22.
Zurück zum Zitat Campbell NP, Villaflor VM. Neoadjuvant treatment of oesophageal cancer. World J Gastroenterol 2010;16:3793–803.PubMedCrossRef Campbell NP, Villaflor VM. Neoadjuvant treatment of oesophageal cancer. World J Gastroenterol 2010;16:3793–803.PubMedCrossRef
Metadaten
Titel
Prognostic Factors for Post-recurrence Survival in Esophageal Squamous Cell Carcinoma Patients with Recurrence after Resection
verfasst von
Po-Kuei Hsu
Bing-Yen Wang
Chien-Sheng Huang
Yu-Chung Wu
Wen-Hu Hsu
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 4/2011
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1458-1

Weitere Artikel der Ausgabe 4/2011

Journal of Gastrointestinal Surgery 4/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.